z-logo
open-access-imgOpen Access
COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
Author(s) -
Ahmed Nafakhi,
Ihsan S. Rabeea,
Rasha AlDarraji,
Hussein Nafakhi,
Ahmed Mechi,
Alhan Al-khalidi
Publication year - 2022
Publication title -
arterial hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 9
eISSN - 2449-6170
pISSN - 2449-6162
DOI - 10.5603/ah.a2022.0005
Subject(s) - medicine , angiotensin receptor blockers , case fatality rate , angiotensin converting enzyme , chest pain , adverse effect , statistical significance , intensive care unit , covid-19 , disease , blood pressure , epidemiology , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom